Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients (2002)
Fonte: Meeting abstracts. Nome do evento: World Congress of Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
ZYNGIER, Szulim Ber et al. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. 2002, Anais.. San Francisco: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2002. . Acesso em: 13 ago. 2024.APA
Zyngier, S. B., Castro, N. S., Ferro, E. S., & Barros, J. C. A. (2002). Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. In Meeting abstracts. San Francisco: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Zyngier SB, Castro NS, Ferro ES, Barros JCA. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. Meeting abstracts. 2002 ;[citado 2024 ago. 13 ]Vancouver
Zyngier SB, Castro NS, Ferro ES, Barros JCA. Determination of BCR_ABL breakpoint in chronic myelogenous leukemia patients. Meeting abstracts. 2002 ;[citado 2024 ago. 13 ]